[
  {
    "ts": "2025-06-10T12:30:00+00:00",
    "headline": "Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users",
    "summary": "ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System.",
    "url": "https://finance.yahoo.com/news/insulet-omnipod-5-app-iphone-123000952.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "26c819de-616f-32fe-9057-d6071cabc3e7",
      "content": {
        "id": "26c819de-616f-32fe-9057-d6071cabc3e7",
        "contentType": "STORY",
        "title": "Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users",
        "description": "",
        "summary": "ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System.",
        "pubDate": "2025-06-10T12:30:00Z",
        "displayTime": "2025-06-10T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8abfc7fab3b4ff691a041f21485081ca",
          "originalWidth": 480,
          "originalHeight": 236,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/myCgk_KzU4A_nhHZhU1dgg--~B/aD0yMzY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8abfc7fab3b4ff691a041f21485081ca.cf.webp",
              "width": 480,
              "height": 236,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FVYbowPUtFkunXj_LZweqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8abfc7fab3b4ff691a041f21485081ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insulet-omnipod-5-app-iphone-123000952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insulet-omnipod-5-app-iphone-123000952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-10T08:36:17+00:00",
    "headline": "PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption",
    "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 28.8% year on year to $569 million. On top of that, next quarter’s revenue guidance ($608.2 million at the midpoint) was surprisingly good and 5.5% above what analysts were expecting. Its non-GAAP profit of $1.02 per share was 29.7% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/podd-q1-earnings-call-insulet-083617515.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "7cc74954-8b26-37ce-8295-82ae1e2b346c",
      "content": {
        "id": "7cc74954-8b26-37ce-8295-82ae1e2b346c",
        "contentType": "STORY",
        "title": "PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption",
        "description": "",
        "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 28.8% year on year to $569 million. On top of that, next quarter’s revenue guidance ($608.2 million at the midpoint) was surprisingly good and 5.5% above what analysts were expecting. Its non-GAAP profit of $1.02 per share was 29.7% above analysts’ consensus estimates.",
        "pubDate": "2025-06-10T08:36:17Z",
        "displayTime": "2025-06-10T08:36:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/dbad5c88980e4c0361704cd6c9719545",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PODD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ovvM9zepj6qBN5ybIDIn7Q--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/dbad5c88980e4c0361704cd6c9719545.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JxYygA5wECz2_NRvIIJ2Ew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/dbad5c88980e4c0361704cd6c9719545.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/podd-q1-earnings-call-insulet-083617515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/podd-q1-earnings-call-insulet-083617515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]